Remove 2019 Remove Healthcare Provider Remove Patients Remove Side effects
article thumbnail

Cancer Patient-Support Program Uptake is Low: Here’s How to Change That

PM360

Cancer-support programs provide vital assistance to patients and their caregivers as they face one of the toughest times of their lives. Yet while patients are interested in these programs, new survey data suggests they aren’t taking advantage of them. We’re committed to serving the entire patient community.”

article thumbnail

The end-of-life care conundrum

pharmaphorum

At the same time, the pharmaceutical industry is creating a greater number of oncology treatments that could provide breakthroughs for patients where none previously existed. Ben Hargreaves examines why there is no easy answer to the question of when palliative care is the right option for patients. The rise of immunotherapies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Almirall/Lilly lebrikizumab offers potential long-term management of atopic dermatitis

pharmaphorum

Atopic dermatitis (AD) is a highly prevalent chronic dermatological disease, with symptoms which include itching, dry skin, severe pain, and inflammation – all of which create considerable stress in the daily lives of patients and often negatively affect their day-to-day and long-term well-being. However, side effects do happen.

article thumbnail

Digital Self-Neuromodulation Therapy for PTSD: Interview with Oded Kraft, CEO of GrayMatters Health

Medgadget

The system uses the patient’s EEG data to calculate a value for the amygdala-derived-EFP biomarker, and meanwhile the patient tries various mental strategies that may help to reduce the value. These treatments at times come with a long list of side effects, leaving many patients in search of an effective long-term solution.

article thumbnail

The evolving role of social media in healthcare

pharmaphorum

Healthcare Provider (HCP) marketing. Back in 2015, the influencer-of-influencers, Kim Kardashian, was slammed for failing to mention the potential side effects of an anti-nausea drug, leading to the US FDA getting involved. Still, many pharma and medical marketers have been reluctant to engage with HCPs on social media.

Media 75
article thumbnail

The Evolving Role of Social Media in Healthcare

Impetus Digital

Healthcare Provider (HCP) Marketing. Back in 2015, the influencer-of-influencers, Kim Kardashian, was slammed for failing to mention the potential side effects of an anti-nausea drug, leading to the US FDA getting involved. Still, many pharma and medical marketers have been reluctant to engage with HCPs on social media.

Media 52
article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

The Health Survey for England 2019 reported that 28% of adults in the UK were obese and 36.2% In the past, obesity medications were often dismissed due to insufficient efficacy data and the fact that they were associated with a high occurrence of side effects. The UK and US are both undergoing an obesity crisis.

Medical 105